Aim of this study is to evaluate the effect of different treatment strategies on overall complications, health related-Quality of Life (hr-QOL) and costs among two subtypes of complex appendicitis in children (\<18 years old). Main research questions: What is the difference in overall complications at three months between: Subgroup 1 (complex appendicitis without abscess/mass formation): Laparoscopic (LA) and open appendectomy (OA) Subgroup 2: (complex appendicitis with abscess/mass formation): Non-operative treatment (NOT) and direct appendectomy
Up till now initiated research projects worldwide mainly focus on simple appendicitis (questioning the necessity of an appendectomy). However, complex appendicitis is associated with significant morbidity (up to 30%), prolonged hospital stay and high costs. Identification of the optimal treatment strategy for children with complex appendicitis is therefore essential. Heterogeneity in the treatment of complex appendicitis still exists in daily practice and reflects the lack of high-quality data and emphasizes the need for well-designed studies. Complex appendicitis can be divided into two subtypes: 1. Complex appendicitis without mass/abscess. (subgroup 1) Although (inter)national guidelines agree that appendectomy should be usual care, the optimal approach (open or laparoscopy) is unclear. Laparoscopic appendectomy (LA) is increasingly applied both in adults (80%) and children (60%). Benefits reported for LA in children are, but not limited to, less superficial site infection (SSI), reduced length of hospital stay and significant less postoperative bowel obstruction compared with open appendectomy (OA). Reluctance for usage of LA in this specific subgroup, however, remains due to the potential higher incidence of post-appendectomy abscess formation (PAA) reported. However, the quality of studies on this topic is low and there is considerable inconsistency in results. 2. Complex appendicitis with mass/abscess. (subgroup 2) The recommendation made in our national guideline (to perform direct appendectomy in this subgroup) is not in line with the available literature. A recent Cochrane review on this topic could only include two trials and stated that no firm conclusions could be drawn. An older systematic review, including 7 studies in children, concluded that non-operative treatment (NOT) led to fewer complications, specifically SSI and PAA, when compared to direct appendectomy. Still the recommendation from our national guideline is to perform a direct appendectomy based upon good experiences in the pediatric academic centers. In order to investigate the optimal treatment for children with complex appendicitis we will perform a nationwide, multi-center, comparative, prospective cohort study. For the purpose of this study, treatment strategies will be standardized among the participating hospitals in order to reduce heterogeneity. Prospectively derived, high quality data will be sufficient to answer the research questions regarding the optimal treatment strategy for each subtype of complex appendicitis in the pediatric population. As it is a non-randomized prospective cohort study, propensity score matching technique will be performed in order to estimate the effect of the treatments adjusted for potential confounders.
Study Type
OBSERVATIONAL
Enrollment
1,308
Laparoscopic appendectomy is performed according to daily practice but with the following standardized key points: 1. Conventional laparoscopy (three-trocar technique) 2. In case of purulent fluid: Suction and no peritoneal lavage procedure 3. Skelletizing of the mesoappendix (coagulation/clips according to routine practice locally) 4. Appendiceal stump closure: with two endoloops and dissected between the endoloops. In case of involvement of the appendiceal base, the use of endostapler is recommended. 5. Withdrawal of appendix: principle of abdominal wall protection is followed (trocar technique / endobag) 6. No drain placement, no nasogastric tube, and no urinary catheter routinely, only on indication. 7. Closure of wounds as appropriate
Open appendectomy will be performed according to the following standardized key points: 1. Gridiron incision at the right lower quadrant. (McBurney's point) 2. After obtaining access to the abdominal cavity the principle of abdominal wall protection will be followed. 3. The appendiceal stump will be closed by ligation, not a purse string suture. 4. Closure of wounds as appropriate
Non-operative treatment consisting of administration of intravenous antibiotics with or without drainage procedures (in case of an abscess), reserving an appendectomy for those not responding or with recurrent disease. One of the two antibiotic regiments: 1. Combination A: 1. Amoxicillin/clavulanic acid 25/2.5mg/kg 6 hourly (total 100/10 mg/kg daily. Maximum 6000/600mg a day) for children \<40 kg OR Amoxicillin/clavulanic acid 1000/200mg/kg 8 hourly (total 3000/6000 mg/kg daily) for children \> 40 kg 2. Gentamicin 7mg/kg once daily 2. Combination B: 1. Cefuroxim 25 mg/kg 6 hourly (total 100 mg/kg/day. Maximum 6gram/day) 2. Metronidazole 10mg/kg 8hourly (total 30 mg/kg/day. Maximum 4000 mg/day) In case of peri-appendicular abscess the decision can be made to perform a drainage procedure either percutaneously or surgical.
laparoscopic or open appendectomy as described
Northwest hospital group
Alkmaar, Netherlands
Flevoziekenhuis
Almere Stad, Netherlands
Meander MC
Amersfoort, Netherlands
Hospital Amstelland
Amstelveen, Netherlands
Amsterdam UMC - Location AMC
Amsterdam, Netherlands
Amsterdam UMC - Location VUmc
Amsterdam, Netherlands
OLVG
Amsterdam, Netherlands
Gelre hospital
Apeldoorn, Netherlands
Rijnstate
Arnhem, Netherlands
Bravis Hospital
Bergen op Zoom, Netherlands
...and 22 more locations
Overall complications
The proportion of patients experiencing any complication within 3 months after inclusion
Time frame: 3 months
Postappendectomy abscess
Proportion patients with a postappendectomy abscess
Time frame: 3 months
Superficial Site Infection
Proportion of patients with a superficial site infection
Time frame: 3 months
Secondary bowel obstruction
Proportion of patients with a secondary/prolonged bowel obstruction
Time frame: 3 months
Days absent from school, social or sports events
Number of days absent from school, social or sports events
Time frame: 30 days, 3 months
Number of days absent from work
Number of days that parents are absent from work
Time frame: 30 days, 3 months
Total number of extra visits
Total number of extra visits to the outpatient clinic, general pratctitioner's office or emergency department
Time frame: 30 days, 3 months
Length of hospital stay
Total length of hospital stay during follow-up due to trategy related treatment or complications
Time frame: 3 months
Level of pain
Level of pain measured according to the Visual Analogue Scale (0-10 points, higher scores indicating worse outcomes)
Time frame: at inclusion/baseline (=day 0), 3 days, 5 days, 30 days, 3 months
Pain medication utilization
Pain medication utilization during admission
Time frame: 30 days, 3 months
Need for appendectomy
Proportion of patients not having to undergo appendectomy within 3 months after start of non-operative treatment
Time frame: 3 months
Recurrent appendicitis
Proportion of patients experiencing recurrent appendicitis within 3 months after inclusion
Time frame: 3 months
Early failure of non-operative treatment
Proportion of patients experiencing early failure of initial non-operative treatment
Time frame: 3 months
Quality of Life questionnaire (EQ-5d-Youth/EQ-5d-Proxy)
QoL measured by the validated EQ-5d-Youth / EQ-5d-Proxy questionnaire (0-1 point, higher scores indicating better outcome)
Time frame: at inclusion/baseline (=day 0), 30 days, 3 months
Quality of Life questionnaire (PedsQL 4.0)
QoL measured by the validated Pediatric Quality of Life Inventory 4.0 (PedsQL 4.0) (0-100 points, higher scores indicating better outcome) Labor Questionnaire (HLQ), Medical Consumption Questionnaire (iMCQ) and Productivity Consumption Questionnaire (iPCQ) and gathered actual health care cost
Time frame: at inclusion/baseline (=day 0), 30 days, 3 months
Medical costs (iMCQ)
Medical costs measured by the iMedical Consumption Questionnaire
Time frame: at inclusion/baseline (=day 0), 30 days, 3 months
Non-medical / indirect costs (iPCQ)
Non-medical / indirect costs measured by the iProductivity Cost Questionnaire
Time frame: at inclusion/baseline (=day 0), 30 days, 3 months
Quality adjusted life months (QALM's)
Quality adjusted life months calculated using outcomes 14 -17
Time frame: 3 months
Patient satisfaction questionnaire (PSQ-18)
Patient satisfaction measured by the Patient Satisfaction Questionnaire (PSQ) (0-100, higher scores indicating better outcome)
Time frame: 3 months
Patient satisfaction questionnaire (Net promotor score)
Patient satisfaction measured by the NET PROMOTOR SCORE (0-10, higher scores indicating better outcome)
Time frame: 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.